Investigation into conolidine has brought about discovery of an opioid receptor in the body termed ACKR3/CXCR7. ACKR3 seems to be one of the most desired goal for conolidine, which also disregards another 4 classical opioid receptors(3). Sign in like a member to learn if there is clinical evidence exhibiting https://brianh420zbc0.verybigblog.com/profile